Weilrod, Germany

Christoph Matthias Schummer

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christoph Matthias Schummer. Retrieved from https://idiyas.com/inventor/christoph-matthias-schummer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christoph Matthias Schummer: Innovator in Veterinary Medicine

Introduction

Christoph Matthias Schummer is a notable inventor based in Weilrod, Germany. He has made significant contributions to veterinary medicine, particularly in the field of cardiology. His work focuses on innovative treatments for heart conditions in animals.

Latest Patents

Schummer holds a patent for a formulation of Pimobendan, which is used for the reduction of heart size and the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease. This patent addresses the needs of mammals, including humans, dogs, cats, and horses, with a particular emphasis on dogs. The invention aims to improve the quality of life for animals suffering from heart conditions.

Career Highlights

Christoph Schummer is associated with Boehringer Ingelheim Vetmedica GmbH, a leading company in veterinary pharmaceuticals. His role at the company has allowed him to focus on developing innovative solutions for animal health, particularly in cardiology.

Collaborations

One of his notable collaborators is Olaf Joens, with whom he has worked on various projects aimed at advancing veterinary medicine.

Conclusion

Christoph Matthias Schummer's contributions to veterinary medicine through his patent on Pimobendan highlight his commitment to improving animal health. His work continues to impact the field positively, providing essential treatments for heart conditions in pets.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…